Editing Scopolamine (section)

== Medical uses ==
Scopolamine has a number of formal uses in modern medicine where it is used in its isolated form and in low doses to treat:<ref name="BNF">{{cite book |isbn = 978-0-85711-084-8 |title = British National Formulary (BNF) | author = Joint Formulary Committee |year = 2013 |publisher = Pharmaceutical Press |location = London, UK |edition = 65 |pages = [https://archive.org/details/bnf65britishnati0000unse/page/49 49, 266, 822, 823] |url = https://archive.org/details/bnf65britishnati0000unse/page/49 }}</ref><ref name="AMH">{{cite book | veditors = Rossi S |isbn = 978-0-9805790-9-3 |title = Australian Medicines Handbook |place = Adelaide |publisher = The Australian Medicines Handbook Unit Trust |year = 2013 |edition = 2013}}</ref>
* [[Postoperative nausea and vomiting]]
* [[Motion sickness]], including [[sea sickness]], leading to its use by [[scuba diver]]s (where it is often applied as a transdermal patch behind the ear)<ref name="pmid1853467">{{cite journal | vauthors = Bitterman N, Eilender E, Melamed Y | title = Hyperbaric oxygen and scopolamine | journal = Undersea Biomedical Research | volume = 18 | issue = 3 | pages = 167–174 | date = May 1991 | pmid = 1853467 | url = http://archive.rubicon-foundation.org/2573 | url-status = usurped | access-date = 13 August 2008 | archive-url = https://web.archive.org/web/20080820004729/http://archive.rubicon-foundation.org/2573 | archive-date = 20 August 2008 }}</ref><ref name="pmid3363755">{{cite journal | vauthors = Williams TH, Wilkinson AR, Davis FM, Frampton CM | title = Effects of transcutaneous scopolamine and depth on diver performance | journal = Undersea Biomedical Research | volume = 15 | issue = 2 | pages = 89–98 | date = March 1988 | pmid = 3363755 | url = http://archive.rubicon-foundation.org/2495 | url-status = usurped | archive-url = https://web.archive.org/web/20080820005139/http://archive.rubicon-foundation.org/2495 | archive-date = 20 August 2008 }}</ref><ref>{{cite journal | vauthors = Williams TH, Wilkinson AR, Davis FM, Frampton CM | title = Effects of transcutaneous scopolamine and depth on diver performance | journal = Undersea Biomedical Research | volume = 15 | issue = 2 | pages = 89–98 | date = March 1988 | pmid = 3363755 }}</ref><ref>{{cite web |title=Motion Sickness |url=https://dan.org/health-medicine/health-resources/diseases-conditions/motion-sickness/ |website=Divers Alert Network |access-date=6 November 2022 |archive-date=6 November 2022 |archive-url=https://web.archive.org/web/20221106213435/https://dan.org/health-medicine/health-resources/diseases-conditions/motion-sickness/ |url-status=live }}</ref>
* [[Gastrointestinal tract|Gastrointestinal]] spasms
* [[Renal tract|Renal]] or [[Biliary tract|biliary]] spasms
* Aid in gastrointestinal [[radiology]] and [[endoscopy]]
* [[Irritable bowel syndrome]]
* [[Clozapine]]-induced [[hypersalivation|drooling]]
* [[Bowel]] [[colic]]
* Eye [[inflammation]]<ref>{{cite web |title=scopolamine solution - ophthalmic, Isopto |url=https://www.medicinenet.com/scopolamine_drops-ophthalmic/article.htm |website=MedicineNet.com |access-date=12 February 2019 |archive-date=31 March 2019 |archive-url=https://web.archive.org/web/20190331204406/https://www.medicinenet.com/scopolamine_drops-ophthalmic/article.htm |url-status=live }}</ref>
It is sometimes used as a [[premedication]], especially to reduce [[respiratory tract]] [[secretions]] in [[surgery]], most commonly by [[Injection (medicine)|injection]].<ref name = BNF/><ref name = AMH/> Common side effects include sleepiness, [[blurred vision]], [[dilated pupils]], and dry mouth.<ref name=AHFS2016/> It is not recommended in people with angle-closure [[glaucoma]] or [[bowel obstruction]].<ref name=AHFS2016/> Whether its use during pregnancy is safe remains unclear, and use during [[breastfeeding]] is still cautioned by health professionals and manufacturers of the drug.<ref name="Briggs 1994">{{cite book | vauthors = Briggs GG, Freeman RK, Yaffe SJ | chapter = Scopolamine |title=Drugs in Pregnancy and Lactation | chapter-url=https://archive.org/details/drugsinpregnancy00gera/page/777 |date=1994 |publisher=Williams and Wilkins |location=Baltimore, Maryland |pages=777–778 |isbn=978-0-683-01060-2 }}</ref>

===Breastfeeding===
Scopolamine enters [[breast milk]] by [[secretion]]. Although no human studies exist to document the safety of scopolamine while nursing, the manufacturer recommends that caution be taken if scopolamine is administered to a breastfeeding woman.<ref name="Briggs 1994"/>